(Q43013472)

12 November 2017

Low grade inflammation is notably suppressed by conventional anti-inflammatory treatment: a randomised crossover trial (English)

1 reference

12 November 2017

Perry CG

1

1 reference

12 November 2017

Cleland SJ

2

1 reference

12 November 2017

Connell JM

3

1 reference

12 November 2017

Petrie JR

4

1 reference

12 November 2017

Sattar N

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

12 November 2017

1 reference

12 November 2017

90

1 reference

12 November 2017

7

1 reference

12 November 2017

804-805

1 reference

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

12 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768325

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768325

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768325

Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1768325

16 August 2018

Identifiers

DOI

10.1136/HRT.2003.022129

1 reference

12 November 2017

1 reference

12 November 2017

PubMed publication ID

15201258

1 reference